A comprehensive review on different approaches for tumor targeting using nanocarriers and recent developments with special focus on multifunctional approaches
Authors:
- 28 July 2022
- journal article
- review article
- Published by Springer Nature in Journal of Pharmaceutical Investigation
- Vol. 52 (5) , 539-585
Abstract
No abstract availableKeywords
This publication has 355 references indexed in Scilit:
- Organelle targeting: third level of drug targetingDrug Design, Development and Therapy, 2013
- Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cellsNucleic Acids Research, 2013
- Targeted drug delivery for cancer therapy: the other side of antibodiesJournal of Hematology & Oncology, 2012
- Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriersInternational Journal of Nanomedicine, 2012
- The extracellular matrix: A dynamic niche in cancer progressionJournal of Cell Biology, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Gold nanocages covered with thermally-responsive polymers for controlled release by high-intensity focused ultrasoundNanoscale, 2011
- Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer DrugsScience, 2010
- Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubblesJournal of Controlled Release, 2009
- Antibody GD3G7 Selected against Embryonic Glycosaminoglycans Defines Chondroitin Sulfate-E Domains Highly Up-Regulated in Ovarian Cancer and Involved in Vascular Endothelial Growth Factor BindingThe American Journal of Pathology, 2007